mounjaro tirzepatide patent expiration date Weight Loss Drugs Get Cheaper As Semaglutide Expires, Generics Flood India, #Semaglutide #PharmaNews #IndianEconomy #WeightLoss #Diabetes #GenericDrugs #StockMarketIndia #BusinessToday In weight loss battle, Novo

Tablet-based weight loss treatments Contain a GLP-1 receptor agonist (the same active ingredient as Wegovy) Taken once daily, rather than once weekly by injection Clinically tested with results comparable to injectable options A non-injectable alternative for those who prefer not to use a pen Easier to fit into everyday life for some people No refrigeration or injection equipment required The same clinically-led approach, in a simpler format Two large clinical trials give us the best picture so far

The goal isnt to eat as little as possible its to eat enough to protect your muscle while the medication handles the rest

The fact that it is highly present in many Indian clinics is indicative of the strong acceptance of it by the medical professionals

In some circumstances, a conditional marketing authorisation may be granted where the benefitrisk balance is positive but further confirmatory data are still awaited